2 completed, 1 terminated. 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Onbrez: new trials by email Literature Review of Onbrez trials Research Report on Onbrez
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ANTES B+ Clinical Trial Trelegy Ellipta 100/62.5/25Mcg Inh 30D, Brimica, Duaklir - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Fundacio Privada Mon Clinic Barcelona | 48 | 2024-02-29 | 2025-08-14 |
| Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve Glycopyrronium, Indacaterol - Asthma | Phase 4 | Completed | University of Saskatchewan | 31 | 2016-10-01 | 2017-06-14 |
| Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD LAS190792 Dose 1, LAS190792 Dose 2, LAS190792 Dose 3 - Chronic Obstructive Pulmonary Disease (COPD), Asthma | Phase 1 | Completed | AstraZeneca | 55 | 2013-09-01 | 2019-06-21 |
Asthma (2) · Pulmonary Disease, Chronic Obstructive (2)
AstraZeneca (1) · Fundacio Privada Mon Clinic Barcelona (1) · University of Saskatchewan (1)
Canada (1) · Spain (1) · United Kingdom (1)
2023 (1)